活動性乾癬性関節炎患者の腱付着部炎に対するトファシチニブの効果: 2つのフェーズ3試験からの統合解析
Arthritis Res Ther. 2023 22;25(1):153 doi: 10.1186/s13075-023-03108-5
Post-hoc analysis of two tofacitinib phase three studies concludes that tofacitinib treatment resulted in improvements in enthesitis in patients with PsA, regardless of baseline location or severity.